Lipoatrophy

Lipoatrophy (disorder)

http://purl.bioontology.org/ontology/SNOMEDCT/248315005

1

Lipoatrophy (disorder)

900000000000448009

X76BY

C1280433

900000000000073002

20150131

http://purl.bioontology.org/ontology/SNOMEDCT/13331008

http://purl.bioontology.org/ontology/SNOMEDCT/55603005

248315005

Lipoatrophy

6011000124106~MAPRULE~IFA 403652001 | Lipoatrophy due to injected corticosteroid |

447562003~MAPADVICE~IF LIPOATROPHY DUE TO HUMAN IMMUNODEFICIENCY VIRUS INFECTION AND TREATMENT CHOOSE B23.8 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

447562003~MAPRULE~TRUE

6011000124106~MAPADVICE~IF LIPOATROPHY CAUSED BY INJECTED DRUG CHOOSE T80.89X? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT | POSSIBLE REQUIREMENT FOR AN EXTERNAL CAUSE CODE

447562003~MAPTARGET~Y42.0

6011000124106~MAPADVICE~IF LIPOATROPHY CAUSED BY INJECTED DRUG CHOOSE E88.1 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPADVICE~IF INSULIN LIPOATROPHY CHOOSE E88.1 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPPRIORITY~4

6011000124106~MAPRULE~IFA 238901000 | Insulin lipoatrophy (disorder) |

6011000124106~MAPADVICE~MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA

447562003~MAPADVICE~IF INSULIN LIPOATROPHY CHOOSE Y42.3 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPADVICE~IF LIPOATROPHY CAUSED BY ANTIRETROVIRAL DRUG CHOOSE T37.5X5? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPTARGET~

6011000124106~MAPCATEGORYID~447638001

6011000124106~MAPTARGET~T38.0X5?

447562003~MAPRULE~IFA 238901000 | Insulin lipoatrophy (disorder) |

6011000124106~MAPGROUP~1

6011000124106~MAPGROUP~2

447562003~MAPGROUP~2

447562003~MAPADVICE~MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA

447562003~MAPADVICE~IF LIPOATROPHY DUE TO HUMAN IMMUNODEFICIENCY VIRUS INFECTION AND TREATMENT CHOOSE E88.1 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT | POSSIBLE REQUIREMENT FOR AN EXTERNAL CAUSE CODE

6011000124106~MAPRULE~IFA 238901000 | Insulin lipoatrophy |

447562003~MAPRULE~IFA 403652001 | Lipoatrophy due to injected corticosteroid (disorder) |

447562003~MAPGROUP~1

447562003~CORRELATIONID~447561005

447562003~MAPRULE~OTHERWISE TRUE

447562003~MAPTARGET~E88.1

447562003~MAPADVICE~IF LIPOATROPHY DUE TO INJECTED CORTICOSTEROID CHOOSE E88.1 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPCATEGORYID~447637006

900000000000509007~ACCEPTABILITYID~900000000000548007

6011000124106~MAPADVICE~IF LIPOATROPHY DUE TO INJECTED DRUG CHOOSE T80.89X? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT | POSSIBLE REQUIREMENT FOR AN EXTERNAL CAUSE CODE

6011000124106~MAPRULE~IFA 403661001 | Lipoatrophy caused by injected drug (disorder) |

447562003~MAPTARGET~B23.8

900000000000508004~ACCEPTABILITYID~900000000000548007

6011000124106~MAPTARGET~E88.1

6011000124106~MAPTARGET~T38.3X5?

447562003~MAPTARGET~

6011000124106~MAPTARGET~T80.89X?

6011000124106~MAPRULE~IFA 403661001 | Lipoatrophy due to injected drug |

447562003~MAPPRIORITY~1

447562003~MAPTARGET~Y42.3

447562003~MAPCATEGORYID~447637006

447562003~MAPADVICE~IF LIPOATROPHY DUE TO INJECTED CORTICOSTEROID CHOOSE Y42.0 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPRULE~OTHERWISE TRUE

447562003~MAPADVICE~IF LIPOATROPHY DUE TO INJECTED DRUG CHOOSE E88.1 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT | POSSIBLE REQUIREMENT FOR AN EXTERNAL CAUSE CODE

6011000124106~MAPADVICE~ALWAYS E88.1 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | DESCENDANTS NOT EXHAUSTIVELY MAPPED

6011000124106~MAPCATEGORYID~447639009

447562003~MAPPRIORITY~3

6011000124106~MAPRULE~IFA 713692003 | Lipoatrophy caused by antiretroviral drug (disorder) |

6011000124106~MAPADVICE~IF INSULIN LIPOATROPHY CHOOSE T38.3X5? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

447562003~MAPCATEGORYID~447639009

6011000124106~MAPADVICE~ALWAYS E88.1 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE

6011000124106~MAPPRIORITY~1

6011000124106~MAPRULE~IFA 713692003 | Lipoatrophy caused by antiretroviral drug |

6011000124106~MAPRULE~IFA 403652001 | Lipoatrophy caused by injected corticosteroid (disorder) |

6011000124106~CORRELATIONID~447561005

447562003~MAPRULE~IFA 403661001 | Lipoatrophy due to injected drug (disorder) |

447562003~MAPPRIORITY~2

900000000000497000~MAPTARGET~X76BY

6011000124106~MAPRULE~TRUE

6011000124106~MAPADVICE~IF LIPOATROPHY DUE TO INJECTED DRUG CHOOSE E88.1 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPPRIORITY~3

6011000124106~MAPADVICE~IF LIPOATROPHY DUE TO INJECTED CORTICOSTEROID CHOOSE T38.0X5? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPPRIORITY~2

447562003~MAPCATEGORYID~447638001

6011000124106~MAPTARGET~T37.5X5?

447562003~MAPADVICE~ALWAYS E88.1

6011000124106~MAPADVICE~IF LIPOATROPHY CAUSED BY INJECTED CORTICOSTEROID CHOOSE T38.0X5? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

447562003~MAPRULE~IFA 129261000119106 | Lipoatrophy due to Human immunodeficiency virus infection and treatment (disorder) |

447562003~MAPPRIORITY~4

T047

900000000000003001

900000000000013009

http://purl.bioontology.org/ontology/SNOMEDCT/362975008

http://purl.bioontology.org/ontology/SNOMEDCT/19660004

http://purl.bioontology.org/ontology/SNOMEDCT/105969002